Trial compares heart implant, warfarin for AF patients

03/1/2013 | MassDevice.com (Boston)

In patients with atrial fibrillation, Boston Scientific's Watchman heart implant performed better than the anticoagulant warfarin in terms of quality-of-life indicators after one year, according to a study published in the Journal of the American College of Cardiology. The study, however, also found that patients who had the implant had a higher risk for serious bleeding.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY